Credit Agricole’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Hold
146,300
﹤0.01% 1091
2026
Q1
$1.21M Buy
146,300
+21,300
+17% +$221K ﹤0.01% 1024
2025
Q4
$1.54M Buy
+125,000
New +$1.34M ﹤0.01% 931
2019
Q3
Sell
-9,000
Closed -$435K 530
2019
Q2
$435K Sell
9,000
-37,000
-80% -$1.77M 0.02% 284
2019
Q1
$2.32M Sell
46,000
-33,916
-42% -$2M 0.13% 181
2018
Q4
$4.74M Buy
79,916
+12,000
+18% +$774K 0.27% 89
2018
Q3
$4.47M Buy
67,916
+31,916
+89% +$1.86M 0.21% 129
2018
Q2
$1.82M Hold
36,000
0.13% 158
2018
Q1
$1.9M Hold
36,000
0.13% 146
2017
Q4
$1.67M Buy
36,000
+10,000
+38% +$421K 0.11% 161
2017
Q3
$1.05M Buy
+26,000
New +$941K ﹤0.01% 1089

Other funds holding EBS

Credit Agricole's EBS Position: Q2 2026 in Review

Credit Agricole held its Emergent Biosolutions (EBS) position steady in Q2 2026 at 146,300 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Credit Agricole first reported a position in EBS in Q3 2017 and has held it in 11 quarters since. The position peaked at $4.74M in Q4 2018. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Credit Agricole held 146,300 shares of Emergent Biosolutions worth $1.23M as of Q2 2026.
  • Credit Agricole left its Emergent Biosolutions share count unchanged in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Credit Agricole's portfolio in Q2 2026, its #1091 holding.
  • Credit Agricole first reported a position in Emergent Biosolutions in Q3 2017 and has held it in 11 quarters since.
  • Credit Agricole's Emergent Biosolutions position peaked at $4.74M in Q4 2018.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.